These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36838665)

  • 1. Exploring the Chemical Space of CYP17A1 Inhibitors Using Cheminformatics and Machine Learning.
    Yu T; Huang T; Yu L; Nantasenamat C; Anuwongcharoen N; Piacham T; Ren R; Chiang YC
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cheminformatic Analysis and Machine Learning Modeling to Investigate Androgen Receptor Antagonists to Combat Prostate Cancer.
    Yu T; Nantasenamat C; Kachenton S; Anuwongcharoen N; Piacham T
    ACS Omega; 2023 Feb; 8(7):6729-6742. PubMed ID: 36844574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning approaches to study the structure-activity relationships of LpxC inhibitors.
    Yu T; Chong LC; Nantasenamat C; Anuwongcharoen N; Piacham T
    EXCLI J; 2023; 22():975-991. PubMed ID: 38023567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Functional Evaluation of Clinically Relevant Inhibitors of Steroidogenic Cytochrome P450 17A1.
    Petrunak EM; Rogers SA; Aubé J; Scott EE
    Drug Metab Dispos; 2017 Jun; 45(6):635-645. PubMed ID: 28373265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents.
    Wróbel TM; Rogova O; Andersen KL; Yadav R; Brixius-Anderko S; Scott EE; Olsen L; Jørgensen FS; Björkling F
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone.
    Garrido M; Peng HM; Yoshimoto FK; Upadhyay SK; Bratoeff E; Auchus RJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():1-10. PubMed ID: 24508512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors.
    Bonomo S; Hansen CH; Petrunak EM; Scott EE; Styrishave B; Jørgensen FS; Olsen L
    Sci Rep; 2016 Jul; 6():29468. PubMed ID: 27406023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Structure-Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents.
    Wróbel TM; Rogova O; Sharma K; Rojas Velazquez MN; Pandey AV; Jørgensen FS; Arendrup FS; Andersen KL; Björkling F
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.
    Yamaoka M; Hara T; Hitaka T; Kaku T; Takeuchi T; Takahashi J; Asahi S; Miki H; Tasaka A; Kusaka M
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):115-28. PubMed ID: 22249003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning Approaches to Investigate the Structure-Activity Relationship of Angiotensin-Converting Enzyme Inhibitors.
    Yu T; Nantasenamat C; Anuwongcharoen N; Piacham T
    ACS Omega; 2023 Nov; 8(46):43500-43510. PubMed ID: 38027387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors.
    Gumede NJ; Nxumalo W; Bisetty K; Escuder Gilabert L; Medina-Hernandez MJ; Sagrado S
    Bioorg Chem; 2020 Jan; 94():103462. PubMed ID: 31818479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing Regimen.
    Cheong EJY; Nair PC; Neo RWY; Tu HT; Lin F; Chiong E; Esuvaranathan K; Fan H; Szmulewitz RZ; Peer CJ; Figg WD; Chai CLL; Miners JO; Chan ECY
    J Pharmacol Exp Ther; 2020 Sep; 374(3):438-451. PubMed ID: 32554434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP17A1: a biochemistry, chemistry, and clinical review.
    Porubek D
    Curr Top Med Chem; 2013; 13(12):1364-84. PubMed ID: 23688130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001.
    DeVore NM; Scott EE
    Nature; 2012 Jan; 482(7383):116-9. PubMed ID: 22266943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental inhibitors of the expression of cytochrome P450 17A1 in mammals.
    Peng Z; Xueb G; Chen W; Xia S
    Environ Toxicol Pharmacol; 2019 Jul; 69():16-25. PubMed ID: 30921671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.
    Cai C; Chen S; Ng P; Bubley GJ; Nelson PS; Mostaghel EA; Marck B; Matsumoto AM; Simon NI; Wang H; Chen S; Balk SP
    Cancer Res; 2011 Oct; 71(20):6503-13. PubMed ID: 21868758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1.
    Gonzalez E; Guengerich FP
    J Biol Chem; 2017 Aug; 292(32):13168-13185. PubMed ID: 28684414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytochrome P450 17A1 conformational selection: modulation by ligand and cytochrome b5.
    Estrada DF; Skinner AL; Laurence JS; Scott EE
    J Biol Chem; 2014 May; 289(20):14310-20. PubMed ID: 24671419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures of human steroidogenic cytochrome P450 17A1 with substrates.
    Petrunak EM; DeVore NM; Porubsky PR; Scott EE
    J Biol Chem; 2014 Nov; 289(47):32952-64. PubMed ID: 25301938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mutations in porcine CYB5A and CYP17A1 on the metabolism of pregnenolone.
    Squires EJ; Gray MA; Lou Y
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105469. PubMed ID: 31509771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.